Logo

Qiagen, Becton JV Sells Molecular Testing Tools to GlaxoSmithKline

Aug 06, 2002

NEW YORK, Aug. 6 - PreAnalytix, a Swiss-based joint venture between Qiagen and Becton Dickinson, has signed on GlaxoSmithKline as a new customer for its molecular-testing tools, PreAnalytix said yesterday.

The company's first product, the PaxGene Blood RNA system, is designed to help gene analysis of blood samples. It was launched in April 2001.

 

PreAnalytix, based in Hombrechtikon, is privately owned.

Breaking News
The Scan

Vaccine Update Recommended

A US Food and Drug Administration panel recommends booster vaccines be updated to target Omicron, CNBC reports.

US to Make More Vaccines for Monkeypox Available

The US is to make nearly 300,000 vaccine doses available in the coming weeks to stem the spread of human monkeypox virus, according to NPR.

Sentence Appealed

The Associated Press reports that Swedish prosecutors are appealing the sentence given to a surgeon once lauded for transplanting synthetic tracheas but then convicted of causing bodily harm.

Genome Biology Papers on COVID-19 Effector Genes, Virtual ChIP-seq, scDART

In Genome Biology this week: proposed COVID-19 effector genes, method to predict transcription factor binding patterns, and more.